507 related articles for article (PubMed ID: 16609730)
21. Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer.
Hong S; Klein EA; Das Gupta J; Hanke K; Weight CJ; Nguyen C; Gaughan C; Kim KA; Bannert N; Kirchhoff F; Munch J; Silverman RH
J Virol; 2009 Jul; 83(14):6995-7003. PubMed ID: 19403677
[TBL] [Abstract][Full Text] [Related]
22. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
Xiang Y; Wang Z; Murakami J; Plummer S; Klein EA; Carpten JD; Trent JM; Isaacs WB; Casey G; Silverman RH
Cancer Res; 2003 Oct; 63(20):6795-801. PubMed ID: 14583476
[TBL] [Abstract][Full Text] [Related]
23. Inflammation, infection, and prostate cancer.
Klein EA; Silverman R
Curr Opin Urol; 2008 May; 18(3):315-9. PubMed ID: 18382242
[TBL] [Abstract][Full Text] [Related]
24. Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant.
Liu X; Schumacher FR; Plummer SJ; Jorgenson E; Casey G; Witte JS
Carcinogenesis; 2007 Jun; 28(6):1232-6. PubMed ID: 17234723
[TBL] [Abstract][Full Text] [Related]
25. Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection.
Garson JA; Kellam P; Towers GJ
Retrovirology; 2011 Feb; 8():13. PubMed ID: 21352548
[TBL] [Abstract][Full Text] [Related]
26. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.
Lombardi VC; Ruscetti FW; Das Gupta J; Pfost MA; Hagen KS; Peterson DL; Ruscetti SK; Bagni RK; Petrow-Sadowski C; Gold B; Dean M; Silverman RH; Mikovits JA
Science; 2009 Oct; 326(5952):585-9. PubMed ID: 19815723
[TBL] [Abstract][Full Text] [Related]
27. RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.
Shea PR; Ishwad CS; Bunker CH; Patrick AL; Kuller LH; Ferrell RE
Prostate; 2008 Mar; 68(4):354-9. PubMed ID: 18189233
[TBL] [Abstract][Full Text] [Related]
28. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.
Maier C; Haeusler J; Herkommer K; Vesovic Z; Hoegel J; Vogel W; Paiss T
Br J Cancer; 2005 Mar; 92(6):1159-64. PubMed ID: 15714208
[TBL] [Abstract][Full Text] [Related]
29. Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
Madsen BE; Ramos EM; Boulard M; Duda K; Overgaard J; Nordsmark M; Wiuf C; Hansen LL
PLoS One; 2008 Jun; 3(6):e2492. PubMed ID: 18575592
[TBL] [Abstract][Full Text] [Related]
30. Carriage of mutations R462Q (rs 486907) and D541E (rs 627928) of the RNASEL gene and risk factors in patients with prostate cancer in Burkina Faso.
Kadanga E; Zouré AA; Zohoncon TM; Traoré L; Ky BD; Yonli AT; Traoré DDA; Bazié BVJTE; Sombié HK; Sorgho PA; Tovo SFA; Traoré K; Ouedraogo TC; Djigma FW; Simpore J
BMC Med Genomics; 2022 Jun; 15(1):123. PubMed ID: 35655265
[TBL] [Abstract][Full Text] [Related]
31. Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer.
Mikovits JA; Huang Y; Pfost MA; Lombardi VC; Bertolette DC; Hagen KS; Ruscetti FW
AIDS Rev; 2010; 12(3):149-52. PubMed ID: 20842203
[TBL] [Abstract][Full Text] [Related]
32. Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines.
Sfanos KS; Aloia AL; Hicks JL; Esopi DM; Steranka JP; Shao W; Sanchez-Martinez S; Yegnasubramanian S; Burns KH; Rein A; De Marzo AM
PLoS One; 2011; 6(6):e20874. PubMed ID: 21698104
[TBL] [Abstract][Full Text] [Related]
33. A scientific journey through the 2-5A/RNase L system.
Silverman RH
Cytokine Growth Factor Rev; 2007; 18(5-6):381-8. PubMed ID: 17681844
[TBL] [Abstract][Full Text] [Related]
34. Lack of detection of XMRV in seminal plasma from HIV-1 infected men in The Netherlands.
Cornelissen M; Zorgdrager F; Blom P; Jurriaans S; Repping S; van Leeuwen E; Bakker M; Berkhout B; van der Kuyl AC
PLoS One; 2010 Aug; 5(8):e12040. PubMed ID: 20706581
[TBL] [Abstract][Full Text] [Related]
35. Genetic variation in RNASEL associated with prostate cancer risk and progression.
Meyer MS; Penney KL; Stark JR; Schumacher FR; Sesso HD; Loda M; Fiorentino M; Finn S; Flavin RJ; Kurth T; Price AL; Giovannucci EL; Fall K; Stampfer MJ; Ma J; Mucci LA
Carcinogenesis; 2010 Sep; 31(9):1597-603. PubMed ID: 20576793
[TBL] [Abstract][Full Text] [Related]
36. RNase L Suppresses Androgen Receptor Signaling, Cell Migration and Matrix Metalloproteinase Activity in Prostate Cancer Cells.
Dayal S; Zhou J; Manivannan P; Siddiqui MA; Ahmad OF; Clark M; Awadia S; Garcia-Mata R; Shemshedini L; Malathi K
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28257035
[TBL] [Abstract][Full Text] [Related]
37. Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection.
Summers K; Crespi B
Infect Genet Evol; 2008 May; 8(3):297-301. PubMed ID: 18295551
[TBL] [Abstract][Full Text] [Related]
38. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
Carpten J; Nupponen N; Isaacs S; Sood R; Robbins C; Xu J; Faruque M; Moses T; Ewing C; Gillanders E; Hu P; Bujnovszky P; Makalowska I; Baffoe-Bonnie A; Faith D; Smith J; Stephan D; Wiley K; Brownstein M; Gildea D; Kelly B; Jenkins R; Hostetter G; Matikainen M; Schleutker J; Klinger K; Connors T; Xiang Y; Wang Z; De Marzo A; Papadopoulos N; Kallioniemi OP; Burk R; Meyers D; Grönberg H; Meltzer P; Silverman R; Bailey-Wilson J; Walsh P; Isaacs W; Trent J
Nat Genet; 2002 Feb; 30(2):181-4. PubMed ID: 11799394
[TBL] [Abstract][Full Text] [Related]
39. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer.
Wiklund F; Jonsson BA; Brookes AJ; Strömqvist L; Adolfsson J; Emanuelsson M; Adami HO; Augustsson-Bälter K; Grönberg H
Clin Cancer Res; 2004 Nov; 10(21):7150-6. PubMed ID: 15534086
[TBL] [Abstract][Full Text] [Related]
40. Ductal variant of prostate adenocarcinoma harbor Xenotropic murine leukemia virus related virus (XMRV) infection: a novel finding in subtype of prostate cancer.
Baig FA; Mirza T; Hamid A; Syed S; Jamal Q
Turk J Urol; 2017 Sep; 43(3):268-272. PubMed ID: 28861296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
